title: Percutaneous transluminal coronary angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levels.
authors.forename: M
authors.initials: M
authors.lastname: Falciani
authors.forename: A M
authors.initials: AM
authors.lastname: Gori
authors.forename: B
authors.initials: B
authors.lastname: Giusti
authors.forename: S
authors.initials: S
authors.lastname: Fedi
authors.forename: M
authors.initials: M
authors.lastname: Capanni
authors.forename: I
authors.initials: I
authors.lastname: Simonetti
authors.forename: M
authors.initials: M
authors.lastname: Margheri
authors.forename: D
authors.initials: D
authors.lastname: Prisco
authors.forename: R
authors.initials: R
authors.lastname: Abbate
authors.forename: G F
authors.initials: GF
authors.lastname: Gensini
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D016022:Case-Control Studies; D003327:Coronary Disease / Q000097:blood / Q000628:therapy; D006801:Humans; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D012008:Recurrence; D016212:Transforming Growth Factor beta / Q000097:blood*
chemical_list: D017395:Plasminogen Activator Inhibitor 1; D016212:Transforming Growth Factor beta